The company was founded in 1997 and its first product was developing a 32 channel EEG device which was completed and sold in 1998. In the following years additional neurology products have been developed including EMG, PSG and TMS devices. The initial sales were to the Czech Republic but soon thereafter were offered in international markets. Due to the high level of innovation and modern design of the products, Deymed has become an established worldwide leader in neurology for both clinical and research applications.
Therapeutic devices have also been a significant part of the product portfolio including EEG Biofeedback and repetitive magnetic stimulators for depression. Deymed strives to continuously improve on and advance their products in a way that brings new possibilities to its users. High signal quality, ease of use, portability and reliability are the hallmarks of Deymed systems.